H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model (2014)
- Authors:
- USP affiliated authors: SCRIDELI, CARLOS ALBERTO - FMRP ; TONE, LUIZ GONZAGA - FMRP ; SERAFINI, LUCIANO NEDER - FMRP
- Unidade: FMRP
- Subjects: MEDULOBLASTOMA; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Pediatric Blood and Cancer
- ISSN: 1545-5009
- Volume/Número/Paginação/Ano: v. 61, suppl. 2, p. S286-S287, res. EP-146, 2014
- Conference titles: Congress of the International Society of Paediatric Oncology (SIOP)
-
ABNT
SCRIDELI, Carlos Alberto et al. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 dez. 2025. , 2014 -
APA
Scrideli, C. A., Cruzeiro, G. A. V., Reis, M. B. F., Eterovic, A. K., Moreno, D. A., Neder, L., et al. (2014). H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Scrideli CA, Cruzeiro GAV, Reis MBF, Eterovic AK, Moreno DA, Neder L, Oliveira RS, Aguiar S, Yunes JA, Brandalise SR, Tone LG, Valera ET. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. 2014 ; 61 S286-S287.[citado 2025 dez. 28 ] -
Vancouver
Scrideli CA, Cruzeiro GAV, Reis MBF, Eterovic AK, Moreno DA, Neder L, Oliveira RS, Aguiar S, Yunes JA, Brandalise SR, Tone LG, Valera ET. H1F1A is overexpressed in medulloblastomas and its inhibition is able in reduce proliferation and increase HIF2A and ATG16L1 methylation levels in a cell line model. Pediatric Blood and Cancer. 2014 ; 61 S286-S287.[citado 2025 dez. 28 ] - Cytogenetic findings in pediatric radiation-induced atypical meningioma after treatment of medulloblastoma: case report and review of the literature
- The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveal BATF2 as a poor prognostic marker for childhood medulloblastoma
- Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma
- Prognostic impact of the expression profile of the hypoxia related genes CA9, CA12, HIF2A, SCL2A1 and VEGF in osteosarcoma and ewing sarcoma
- Tetraploidization in Wilms tumor in an infant
- Bloom's and myelodysplastic syndromes: report of a rare pediatric case with gain of an isochromosome 5p. [Carta]
- Alternative targets for medulloblastoma treatment: polo-like kinase 1
- Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines
- Inibição de exportina 7 (XPO7) sensibiliza linhagens de leucemia linfóide aguda para o tratamento com glicocorticoide
- Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
